A novel, semi-synthetic diterpenoid 16(R and S)-phenylamino-cleroda-3,13(14), Z-dien-15,16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway
Neuroblastoma being the most common extracranial pediatric solid tumor accounts for 15% of overall cancer-related childhood mortalities. Resistance to chemotherapeutic drugs is one of the limiting factors for positive prognosis for neuroblastoma. Therefore, there is always a need for developing new therapeutic moieties which can become a future prospect of neuroblastoma therapy. Terpenoids being the largest natural compounds have demonstrated many biological activities including anticancer activity. Keeping in mind the role of terpenoids in biological system, we aimed to identify novel semi-synthetic terpenoid derived from cleroda diterpene, 16-oxo-cleroda-3,13(14)E-diene-15-oic acid (1) as a potential anticancer moiety against neuroblastoma. We choose γ-amino γ-lactone (PGEA-AN, 2) of 1 to study further because it exhibited the most potent cytotoxic activity in preliminary screening. In comparison to cisplatin, PGEA-AN significantly decreased the nuclear area factor which suggest the potential apoptosis as cause of cell death. PGEA-AN demonstrated a significant increase in the percent of late apoptosis and necrotic cell death at 48-h treatment with IC50 dose. PGEA-AN significantly increased expression of P53 and BAX with no or little effect on BCL2 shifting BAX/BCL2 towards BAX promoting apoptosis. Increment in mitochondrial permeability supports P53 pathway involvement. Despite similarity in actions with cisplatin, PGEA-AN has found to have no effect on renal system. Based on these observations, we suggest that PGEA-AN modulates P53 system which further leads to the death of the neuroblastoma cells with no effect on renal system in vivo owing it to be a future prospect for development of anticancer moiety against neuroblastoma.
KeywordsNeuroblastoma Diterpenoids Synthetic γ-lactone Polyalthia longifolia var. pendula P53
Compliance with ethical standards
Conflict of interest
There is no conflict of interest to disclose.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
- 7.Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children’s oncology group study. J Clin Oncol 27:1007–1013CrossRefPubMedPubMedCentralGoogle Scholar
- 9.American Cancer Society (2017) Chemotherapy for neuroblastoma. https://www.cancer.org/cancer/neuroblastoma/treating/chemotherapy.html. Accessed 14 Oct 2017
- 12.Rubeena S, Ahmed M, Ahmed SI, Azeem M, Khan RA, Rasool M, Saleem H, Noor F, Faizi S (2005) Hypotensive activity and toxicology of constituents from root bark of Polyalthia longifolia var. pendula. Phytother Res 10:881–884Google Scholar
- 22.Strachan T, Read AP (1999) Chapter 18, cancer genetics. Human Molecular Genetics 2Google Scholar
- 28.DeCoster MA (2007) The nuclear area factor: a measure for cell apoptosis using microscopy and image analysis. Modern research and educational topics in microscopy 378–384Google Scholar
- 29.Bron D, Mark A (2007) Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining. Brain Res Protoc 13:144–150Google Scholar
- 32.Liu Y, Whelan RJ, Pattnaik BR, Ludwig K, Subudhi E, Rowland H, Claussen N, Zucker N, Uppal S, Kushner DM, Felder M (2012) Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PLoS ONE 7(12):e53178CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Kobayashi T, Sawa H, Morikawa J, Zhang W, Shiku H (2000) BAX induction activates apoptotic cascade via mitochondrial cytochrome c release and BAX overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells. Cancer Sci 91(12):1264–1268Google Scholar